Sarlak Saharnaz: Difference between revisions
From Bioblast
m (Kandolf Georg moved page Saharnaz Sarlak to Saharnaz S) |
m (Gurkina Angelina moved page Sarlak S to Sarlak Saharnaz over redirect) Β |
||
(5 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | |||
|COST= Member | |||
|COST WG1=WG1 | |||
}} | |||
{{Person | {{Person | ||
|lastname= | |lastname=Sarlak | ||
|firstname= | |firstname=Saharnaz | ||
|title=MSc | |title=MSc | ||
|institution=INSERM U1211 Rare Diseases, Genetics and Metabolism | |institution=INSERM U1211 Rare Diseases, Genetics and Metabolism, | ||
University of Bordeaux | Β | ||
CHU Pellegrin, | |||
Β | |||
University of Bordeaux, FR | |||
Β | |||
'''PhD. Student''' | '''PhD. Student''' | ||
Line 17: | Line 24: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | |||
::::* [[IOC137| IOC137 Innsbruck AT]] |
Latest revision as of 10:40, 17 March 2020
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Sarlak Saharnaz
MitoPedia topics: EAGLE
Name | Sarlak Saharnaz, MSc |
---|---|
Institution | INSERM U1211 Rare Diseases, Genetics and Metabolism,
CHU Pellegrin, University of Bordeaux, FR
|
Address | Place AmΓ©lie Raba LΓ©on, Ecole des Sages Femmes, Γ©tage 2, 33000 |
City | Bordeaux |
State/Province | |
Country | France |
[email protected] | |
Weblink | https://mrgm.u-bordeaux.fr/ |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Amoedo 2021 J Clin Invest | 2021 | Amoedo ND, Sarlak S, Obre E, Esteves P, BΓ©gueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, Dard L, Redonnet-Vernhet I, Punzi G, Rodrigues MF, Dumon E, Mafhouf W, Guyonnet-DupΓ©rat V, Gales L, Palama T, Bellvert F, Dugot-Senan N, Claverol S, Baste JM, Lacombe D, Rezvani HR, Pierri CL, Mechta-Grigoriou F, Thumerel M, Rossignol R (2021) Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest 131:e133081. |
Bastos Sant'Anna Silva 2021 Cancers (Basel) | 2021 | Bastos Sant'Anna Silva AC, Perez Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. https://doi.org/10.3390/cancers13071727 |
BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al β MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
Esteves 2019 Oncogene | 2019 | Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, Dumon E, Izotte J, Bonneu M, Lacombe D, Dupuy JW, Amoedo N, Rossignol R (2019) Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene 39:617-36. |